{{Infobox company
| | name = Mondobiotech | logo = | type = Public | former_name = | successor = Relief Therapeutics | founded = 2000 | defunct = 2016 | hq_location = Stans, Switzerland | key_people = | industry = Pharmaceutical | products = | num_employees = | website = }}
'''Mondobiotech''' was a Swiss-based biotechnology company focused on developing human peptides as medicaments for patients affected by rare diseases.
==History== Mondobiotech was founded in 2000 by Fabio Cavalli and Dorian Bevec.<ref>{{cite web |url=http://www.mondobiotech.com/media/newsarchive/item/15351 |title=Mondobiotech |accessdate=2012-02-29 |url-status=dead |archiveurl=https://web.archive.org/web/20120720214623/http://www.mondobiotech.com/media/newsarchive/item/15351 |archivedate=2012-07-20 }}</ref> The company listed on the Zurich exchange in 2009.<ref>{{cite web | url = https://www.reuters.com/article/mondobiotech-idUSLQ654812200908261| publisher = Reuters| date = August 26, 2009 | accessdate=November 5, 2021 |title = Swiss Mondobiotech to list on Zurich exchange}}</ref> In March 2012, ''Pharma Times'' in exclusive negotiations with Pierrel Research, the contact research division of the Italian company Pierrel.<ref name="Pharma Times 6 March 2012">{{cite news | title= Pierrel in negotiations for mondoBIOTECH merger |url= http://www.pharmatimes.com/Article/12-03-06/Pierrel_in_negotiations_for_mondoBIOTECH_merger.aspx| last= Mansell | first= Peter | date= 6 March 2012| newspaper= Pharma Times | accessdate= 9 March 2015}}</ref>
==Research and development== Mondobiotech created drugs for rare diseases.
==Achievements== *Winner of the Swiss Life Sciences Prize 2005. *Selected Technology Pioneer 2008 by The World Economic Forum.
==Notes and references== {{Reflist|2}}
== See also == * List of pharmaceutical companies * Pharmaceutical industry in Switzerland
{{Portal bar|Companies|Switzerland}}
Category:Pharmaceutical companies of Switzerland